Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

NuVasive, Inc. (NUVA), Medtronic, Inc. (MDT) & Three Earnings Reports That Caught My Attention Last Week

As we enter the heart of second-quarter earnings reports, I can’t help but point out that the majority we’ve covered over the past year have been better than expected. With so many companies reporting during the weeks that comprise earnings season, it’s easy for some earnings reports to fall through the cracks.

Each week for the past year, I’ve taken a look at three companies that could be worth further research after either beating or missing their profit expectations. Today, we’ll take a gander at three more companies that reported earnings last week. They may have slid under your radar, but they deserve a look.

Company Consensus EPS Reported EPS Surprise
NuVasive (NASDAQ:NUVA) $0.22 $0.26 18%
FLY Leasing (NYSE:FLY) $0.76 $1.15 51%
FreightCar America (NASDAQ:RAIL) $0.06 ($0.18) (400%)

Source: Yahoo! Finance.

NuVasive, Inc. (NASDAQ:NUVA), a surgical device company that makes spinal implants, reported Street-topping results yet again last Tuesday. Having topped estimates by an average of 27% over the last four quarters, NuVasive, Inc. (NASDAQ:NUVA) delivered 5% sales growth and a higher gross profit despite a small 20-basis-point drop in gross margin to 75.5%.

However, the fact that the company topped estimates yet again wasn’t what interested me; nor was it the fact that it stuck to its full-year adjusted EPS forecast of $1. The interesting tidbit in NuVasive, Inc. (NASDAQ:NUVA)’s report was that its expenses ticked higher due to “international infrastructure expansion” as its earnings report states.

If you recall, NuVasive, Inc. (NASDAQ:NUVA)’s CEO, Alex Lukianov, took out an op-ed in the San Diego Union Tribune in June of last year to describe the negative impact that the Patient Protection and Affordable Care Act, also known as Obamacare, was going to have on his company’s bottom line. Specifically, Lukianov noted that with 100% of its R&D and 90% of its manufacturing done in the U.S., it was going to face shrinking margins. This report signals very clearly that NuVasive, Inc. (NASDAQ:NUVA) is beginning to move more aspects of its manufacturing and perhaps R&D overseas.

This wouldn’t actually be surprising, as Medtronic, Inc. (NYSE:MDT), another large medical-device maker that specializes in spinal implants, announced last year that it’d be hiring up to 1,500 people, but noted that the majority of these hires would be overseas. Overseas markets certainly supply cheaper labor potential, but they also offer friendlier tax environments. As NuVasive expands its global presence, expect its profits to improve.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.